Cyclodextrin (CD) complexes of cholesterol - Their potential use in reducing dietary cholesterol intake

Pharmazie

Volumn 61, Issue 2, 2006, Pages 154-156

  Somogyi, Gabor ^a,c   Posta, J ^b   Buris, L ^b   Varga, M ^b  

^a National Institute of Forensic Toxicology   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c National Institute of Forensic Toxicology   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ALPHA CYCLODEXTRIN; BETA CYCLODEXTRIN; CHOLESTEROL; CYCLODEXTRIN DERIVATIVE; GAMMA CYCLODEXTRIN; O,O DIMETHYL BETA CYCLODEXTRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL INTAKE; COMPLEX FORMATION; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MOUSE; NONHUMAN; SOLUBILITY; STOMACH TUBE; SWEETNESS;

ANIMALS; CHOLESTEROL; CHOLESTEROL, DIETARY; CYCLODEXTRINS; INTESTINAL ABSORPTION; INTUBATION, GASTROINTESTINAL; MALE; MICE; MICE, INBRED C57BL; SOLUBILITY; SOLUTIONS;

EID: 33644536149     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Brewster ME, Loftsson T, Estes KE, Lin J-L, Fridriksdottir H, Bodor N (1992) Effect of various cyclodextrins on solution stability and dissolution rate of doxorubicin hydrochloride. Int J Pharm 79: 289-299.
2. Frijlink HW, Visser J, Hefting NR, Oosting R, Meijer DKF, Lerk CF (1990) The pharmacokinetics of beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin in the rat. Pharm Res 7: 1248-1252.
3. Frijlink HW, Eissens AC, Hefting NR, Poelstra K, Lerk CF, Meijer DK (1991) The effect of parenterally administered cyclodextrins on cholesterol levels in the rat. Pharm Res 8: 9-16.
4. Gale AE (1985) Health for all by the year 2000. Wellness Letter. University of California, Berkeley, July
5. Garcia-Mediavilla V (2003) Effects of dietary beta-cyclodextrin in hypercholesterolaemic rats. Pharmacol Toxicol 92: 94-99.
6. Irie T, Fukunaga K, Yoshida A, Uekama K, Fales HM, Pitha J. (1988) Amorphous water-soluble cyclodextrin derivatives: 2-hydroxyethyl, 3-hydroxypropyl, 2-hydroxyisobutyl, and carboxamidomethyl derivatives of beta-cyclodextrin. Pharm Res 5: 713-717.
7. Loftsson T, Bodor N (1989) Effects of 2-hydroxypropyl-beta-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17 beta-estradiol. Acta Pharm Nord 1: 185-194.
8. Nishijo J, Moriyama S, Shiota S, Kamigauchi M., Sugiura M. (2004) Interaction of heptakis (2,3,6-tri-O-methyl)-beta-cyclodextrin with cholesterol in aqueous solution. Chem Pharm Bull 52: 1405-1410.
9. Pitha J, Anaissie EJ, Uekama K. (1987) Gamma-cyclodextrin: testosterone complex suitable for sublingual administration. Pharm Sci 76: 788-790.
10. Riottot M, Olivier P, Huet A, Caboche J-J, Parquet M, Khallou J, Lutton C (1993) Hypolipidemic effects of beta-cyclodextrin in the hamster and in the genetically hypercholesterolemic Rico rat. Lipids 28: 181-188.
11. Small DM, Shipley GG (1974) Physical-chemical basis of lipid deposition in atherosclerosis. Science 185: 222-229.
12. Szejtli J (1982) Cyclodextrins and their inclusion complexes. Ed. Akadémia Kiadó, Budapest
13. Yoshida A, Arima H, Uekama K, Pitha J (1988) Pharmaceutical evaluation of hydroxyalkyl ethers of β-cyclodextrins. Int J Pharm 46: 217-222.